Analyst Expectations for 2seventy bio's Future
Portfolio Pulse from Benzinga Insights
In the last quarter, 2seventy bio (NASDAQ:TSVT) received 5 analyst ratings, with 1 being bullish, 3 somewhat bullish, and 1 indifferent. The average price target is $22.0, representing an upside from the current price of $6.03. However, this average price target is a 16.98% decrease from the previous average price target of $26.50.
August 15, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
2seventy bio received mostly positive analyst ratings in the last quarter, with an average price target of $22.0, indicating potential upside from the current price. However, the new target is lower than the previous one.
The majority of the analyst ratings for 2seventy bio are positive, suggesting a potential increase in the stock price. However, the decrease in the average price target compared to the previous one might indicate less optimism about the stock's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100